Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADRENL - ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children, Pilot Study

NCT03408405 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT03408405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03408405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADRENL - ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children, Pilot Study
Lead sponsor
Rhode Island Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
June 30, 2018
Completion date
July 31, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-resistant nephrotic syndrome